Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants

  1. Bove, R.
  2. Hellwig, K.
  3. Pasquarelli, N.
  4. Borriello, F.
  5. Dobson, R.
  6. Oreja-Guevara, C.
  7. Lin, C.-J.
  8. Zecevic, D.
  9. Craveiro, L.
  10. McElrath, T.
  11. Vukusic, S.
Revista:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Any de publicació: 2022

Volum: 64

Tipus: Article

DOI: 10.1016/J.MSARD.2022.103963 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus